← All organizations

Action Research Group

Academic/Hospital

Also known as: Action Research Group

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Oct 1, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (7 distinct, 5 trials)

Phase 4 (1 own, 0 via acquisition)

evolocumab

Phase 3 (6 own, 0 via acquisition)

Indications

Studied for

Recent trials (5)

NCT06215378CollaboratorPhase 3Oct 1, 2024
NCT04951856CollaboratorPhase 4Sep 29, 2021
NCT03273322CollaboratorPhase 2/Phase 3Sep 13, 2017
NCT02617290CollaboratorPhase 3Jan 9, 2017
NCT02664649CollaboratorPhase 3Aug 26, 2016

Details

Last known activity: Oct 1, 2024